If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

NBIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.40%

Insider Buying (Last 12 Months): $39,032,821.44

Insider Selling (Last 12 Months): $28,316,749.32

Neurocrine Biosciences Insider Trading History Chart

Neurocrine Biosciences Share Price & Price History

^$99.21

▲ +2.11 (2.17%)

As of 03/30/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Neurocrine Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/23/2023	Neurocrine Biosciences Inc	Major Shareholder	Buy	4,395,588	$8.88	$39,032,821.44	8,575,316
2/8/2023	Eric Benevich	Insider	Sell	980	$104.12	$102,037.60	34,381
2/8/2023	Kevin Charles Gorman	CEO	Sell	2,274	$104.30	$237,178.20	491,365
2/7/2023	Matt Abernethy	CFO	Sell	26,328	$102.40	$2,695,987.20	24,333
2/6/2023	Eric Benevich	Insider	Sell	1,280	$105.63	$135,206.40	17,879
2/6/2023	Kevin Charles Gorman	CEO	Sell	3,040	$105.68	$321,267.20	468,008
1/31/2023	Eiry Roberts	Insider	Sell	1,457	$109.99	$160,255.43	26,171
1/31/2023	Kevin Charles Gorman	CEO	Sell	2,707	$110.08	$297,986.56	465,278
1/31/2023	Matt Abernethy	CFO	Sell	1,283	$109.98	$141,104.34	21,357
1/6/2023	Eric Benevich	Insider	Sell	400	$125.00	$50,000.00	15,643
1/3/2023	Stephen A. Sherwin	Director	Sell	30,000	$118.86	$3,565,800.00	25,055
11/30/2022	Eric Benevich	Insider	Sell	50,000	$125.90	$6,295,000.00	15,643
11/10/2022	Eric Benevich	Insider	Sell	100	$125.36	$12,536.00	15,643
11/8/2022	Eric Benevich	Insider	Sell	24,593	$125.33	$3,082,240.69	15,643
11/3/2022	Darin Lippoldt	Insider	Sell	4,518	$125.02	$564,840.36	29,234
11/1/2022	Darin Lippoldt	Insider	Sell	10,000	$120.09	$1,200,900.00	29,234
10/31/2022	Gary A. Lyons	Director	Sell	15,000	$114.76	$1,721,400.00	203,697
10/27/2022	Darin Lippoldt	Insider	Sell	4,923	$115.04	$566,341.92	29,234
10/17/2022	Eric Benevich	Insider	Sell	4,960	$110.82	$549,667.20	15,643
10/4/2022	Gary A. Lyons	Director	Sell	5,000	$110.54	$552,700.00	203,697
10/3/2022	David W. Boyer	Insider	Sell	1,437	$106.59	$153,169.83	4,214
8/12/2022	Malcolm Lloyd-Smith	Insider	Sell	21,533	$105.95	$2,281,421.35	18,888
6/27/2022	Julie Cooke	Insider	Sell	754	$100.00	$75,400.00	16,918
5/9/2022	Richard F. Pops	Director	Sell	15,000	$76.30	$1,144,500.00	29,512
4/25/2022	Gary A. Lyons	Director	Sell	15,000	$92.76	$1,391,400.00	208,697
4/1/2022	William H. Rastetter	Director	Sell	10,728	$94.93	$1,018,409.04	34,022
3/22/2022	Darin Lippoldt	Insider	Sell	8,455	$95.05	$803,647.75
3/18/2022	Darin Lippoldt	Insider	Sell	300	$95.00	$28,500.00
2/7/2022	David W. Boyer	Insider	Sell	240	$81.07	$19,456.80
2/7/2022	Kevin Charles Gorman	CEO	Sell	8,710	$80.82	$703,942.20
2/7/2022	Matt Abernethy	CFO	Sell	3,310	$80.79	$267,414.90
1/24/2022	Stephen A. Sherwin	Director	Sell	15,000	$74.43	$1,116,450.00
1/10/2022	Eiry Roberts	Insider	Sell	2,632	$74.50	$196,084.00
1/5/2022	Kyle Gano	Insider	Sell	28,266	$85.50	$2,416,743.00
12/1/2021	Matt Abernethy	CFO	Sell	1,645	$82.59	$135,860.55
10/7/2021	Dimitri E. Grigoriadis	Insider	Sell	8,000	$104.81	$838,480.00
10/7/2021	Gary A. Lyons	Director	Sell	5,000	$105.06	$525,300.00
10/4/2021	Julie Cooke	Insider	Sell	987	$101.73	$100,407.51
8/16/2021	Eric Benevich	Insider	Sell	5,628	$89.62	$504,381.36
7/27/2021	Malcolm Lloyd-Smith	Insider	Sell	16,709	$93.80	$1,567,304.20	15,801
6/10/2021	Gary A. Lyons	Director	Sell	10,000	$100.27	$1,002,700.00
2/10/2021	Malcolm Lloyd-Smith	Insider	Sell	1,700	$119.96	$203,932.00	33,610
2/8/2021	Eiry Roberts	Insider	Sell	2,363	$116.78	$275,951.14	17,231
2/8/2021	Kevin Charles Gorman	CEO	Sell	10,466	$116.75	$1,221,905.50	443,249
2/8/2021	Matt Abernethy	CFO	Sell	2,910	$116.82	$339,946.20	13,043
2/5/2021	Kevin Charles Gorman	CEO	Sell	2,422	$114.16	$276,495.52	443,249
2/5/2021	Malcolm Lloyd-Smith	Insider	Sell	865	$114.15	$98,739.75	29,675
1/26/2021	Malcolm Lloyd-Smith	Insider	Sell	1,100	$119.97	$131,967.00	33,013
1/25/2021	Gary A. Lyons	Director	Sell	1,600	$120.03	$192,048.00
1/8/2021	Eiry Roberts	Insider	Sell	2,632	$111.06	$292,309.92	15,845
1/8/2021	Kevin Charles Gorman	CEO	Sell	308,250	$110.22	$33,975,315.00	584,520
12/1/2020	Matt Abernethy	CFO	Sell	1,645	$94.66	$155,715.70	11,494
11/12/2020	Eric Benevich	Insider	Sell	2,257	$90.71	$204,732.47	17,405
11/12/2020	Kevin Charles Gorman	CEO	Sell	3,390	$90.78	$307,744.20	441,071
11/2/2020	Eric Benevich	Insider	Sell	20,595	$96.53	$1,988,035.35	35,969
10/2/2020	Julie Cooke	Insider	Sell	987	$95.26	$94,021.62	9,549
8/5/2020	Eiry Roberts	Insider	Sell	2,257	$118.84	$268,221.88	11,446
8/5/2020	Kevin Charles Gorman	CEO	Sell	3,390	$118.91	$403,104.90	438,021
7/9/2020	Darin Lippoldt	Insider	Sell	1,657	$136.02	$225,385.14	27,678
6/23/2020	Eiry Roberts	Insider	Sell	5,000	$130.00	$650,000.00	14,416
5/18/2020	Darin Lippoldt	Insider	Sell	5,000	$120.00	$600,000.00	31,021
5/12/2020	Haig P Bozigian	Insider	Sell	61,555	$114.94	$7,075,131.70	157,727
5/7/2020	Dimitri E. Grigoriadis	Insider	Sell	8,682	$105.44	$915,430.08	104,741
5/7/2020	Matt Abernethy	CFO	Sell	15,000	$110.21	$1,653,150.00	20,953
4/28/2020	Matt Abernethy	CFO	Sell	1,741	$102.49	$178,435.09	5,953
4/28/2020	Stephen A. Sherwin	Director	Sell	17,687	$99.39	$1,757,910.93	29,861
4/24/2020	Eiry Roberts	Insider	Sell	1,934	$99.47	$192,374.98
4/24/2020	Kevin Charles Gorman	CEO	Sell	2,906	$99.45	$289,001.70	434,971
4/15/2020	Eric Benevich	Insider	Sell	8,632	$94.65	$817,018.80

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Neurocrine Biosciences (NASDAQ:NBIX)

92.58% of Neurocrine Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Neurocrine Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/27/2023	Neo Ivy Capital Management	2,682	$0.32M	0.2%	+1,390.0%	0.003%
3/10/2023	Victory Capital Management Inc.	113,338	$13.54M	0.0%	+15.8%	0.117%
2/28/2023	Voya Investment Management LLC	161,811	$19.33M	0.0%	+29.4%	0.168%
2/24/2023	Natixis	44,649	$5.33M	0.0%	N/A	0.046%
2/22/2023	Teachers Retirement System of The State of Kentucky	42,812	$5.11M	0.1%	+81.5%	0.044%
2/21/2023	Macquarie Group Ltd.	285,314	$34.08M	0.0%	-0.3%	0.295%
2/21/2023	Wallace Advisory Group LLC	1,702	$0.20M	0.2%	N/A	0.002%
2/21/2023	Northwestern Mutual Investment Management Company LLC	8,897	$1.06M	0.0%	-35.6%	0.009%
2/17/2023	Truist Financial Corp	42,338	$5.06M	0.0%	-3.9%	0.044%
2/17/2023	Coppell Advisory Solutions Corp.	423	$51K	0.0%	N/A	0.000%
2/17/2023	Covenant Partners LLC	1,943	$0.23M	0.1%	N/A	0.002%
2/17/2023	Linden Thomas Advisory Services LLC	15,024	$1.79M	0.5%	N/A	0.016%
2/16/2023	DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main	52,147	$6.23M	0.0%	+48.1%	0.054%
2/16/2023	Axxcess Wealth Management LLC	10,664	$1.27M	0.1%	N/A	0.011%
2/16/2023	American Trust	6,530	$0.78M	0.1%	N/A	0.007%
2/16/2023	Alliancebernstein L.P.	166,861	$19.93M	0.0%	+7.5%	0.173%
2/16/2023	HealthCor Management L.P.	20,000	$2.39M	2.2%	-7.9%	0.021%
2/16/2023	Point72 Middle East FZE	4,507	$0.54M	0.0%	N/A	0.005%
2/16/2023	State of Wyoming	1,756	$0.21M	0.1%	+487.3%	0.002%
2/15/2023	Public Employees Retirement System of Ohio	48,584	$5.80M	0.0%	+2.1%	0.051%
2/15/2023	MetLife Investment Management LLC	64,270	$7.68M	0.1%	-1.6%	0.067%
2/15/2023	State of Tennessee Treasury Department	46,279	$5.53M	0.0%	+27.6%	0.048%
2/15/2023	Apollon Wealth Management LLC	1,734	$0.21M	0.0%	N/A	0.002%
2/15/2023	Utah Retirement Systems	16,783	$2.01M	0.0%	-1.2%	0.017%
2/15/2023	Captrust Financial Advisors	2,946	$0.35M	0.0%	+52.7%	0.003%
2/15/2023	Lazard Asset Management LLC	4,235	$0.51M	0.0%	+252.0%	0.004%
2/15/2023	1832 Asset Management L.P.	691,400	$82.58M	0.2%	+45.6%	0.719%
2/15/2023	Bridgefront Capital LLC	2,894	$0.35M	0.2%	N/A	0.003%
2/15/2023	Cerity Partners LLC	3,239	$0.39M	0.0%	+19.7%	0.003%
2/15/2023	Vestcor Inc	13,442	$1.61M	0.1%	+91.6%	0.014%
2/15/2023	State of Wisconsin Investment Board	64,195	$7.67M	0.0%	-8.5%	0.067%
2/15/2023	Schonfeld Strategic Advisors LLC	47,600	$5.69M	0.0%	-31.5%	0.050%
2/15/2023	Squarepoint Ops LLC	33,522	$4M	0.0%	-41.9%	0.035%
2/15/2023	Legal & General Group Plc	491,222	$58.67M	0.0%	-1.2%	0.511%
2/15/2023	Lombard Odier Asset Management Switzerland SA	137,450	$16.42M	1.3%	-31.0%	0.143%
2/15/2023	Mackenzie Financial Corp	39,469	$4.71M	0.0%	+11.3%	0.041%
2/15/2023	Marietta Investment Partners LLC	3,580	$0.43M	0.1%	N/A	0.004%
2/15/2023	Millennium Management LLC	840,340	$100.37M	0.1%	+46.6%	0.874%
2/15/2023	Money Concepts Capital Corp	467	$56K	0.0%	N/A	0.000%
2/15/2023	Man Group plc	315,970	$37.74M	0.1%	+199.0%	0.329%
2/15/2023	Mariner LLC	10,597	$1.27M	0.0%	-10.0%	0.011%
2/15/2023	Nissay Asset Management Corp Japan ADV	10,825	$1.29M	0.0%	-2.1%	0.011%
2/15/2023	Norges Bank	935,915	$111.79M	0.0%	N/A	0.974%
2/15/2023	E Fund Management Co. Ltd.	3,606	$0.43M	0.0%	-19.4%	0.004%
2/15/2023	Eagle Asset Management Inc.	278,485	$33.44M	0.2%	N/A	0.290%
2/15/2023	EAM Global Investors LLC	16,774	$2M	0.5%	N/A	0.017%
2/15/2023	EAM Investors LLC	13,187	$1.58M	0.3%	-1.2%	0.014%
2/15/2023	Echo Street Capital Management LLC	2,036	$0.24M	0.0%	N/A	0.002%
2/15/2023	Fjarde AP Fonden Fourth Swedish National Pension Fund	21,800	$2.60M	0.0%	-19.6%	0.023%
2/15/2023	Fred Alger Management LLC	206,697	$24.69M	0.1%	+92,175.4%	0.215%
2/15/2023	FinTrust Capital Advisors LLC	2,500	$0.30M	0.1%	N/A	0.003%
2/15/2023	Allstate Investment Management Co.	4,215	$0.50M	0.0%	N/A	0.004%
2/15/2023	AQR Capital Management LLC	106,535	$12.69M	0.0%	-6.2%	0.111%
2/15/2023	Armistice Capital LLC	900,000	$107.50M	1.9%	-32.0%	0.936%
2/15/2023	Artia Global Partners LP	45,000	$5.38M	2.0%	N/A	0.047%
2/15/2023	Ascendant Capital Management LLC	3,000	$0.36M	1.1%	N/A	0.003%
2/15/2023	Avidity Partners Management LP	1,780,000	$212.60M	4.6%	-4.1%	1.852%
2/15/2023	Axxcess Wealth Management LLC	10,664	$1.27M	0.1%	N/A	0.011%
2/15/2023	Caisse DE Depot ET Placement DU Quebec	44,376	$5.30M	0.0%	+94.0%	0.046%
2/15/2023	Jefferies Financial Group Inc.	22,231	$1.73M	0.0%	N/A	0.023%
2/14/2023	Meeder Asset Management Inc.	1,227	$0.15M	0.0%	-72.3%	0.001%
2/14/2023	Baader Bank Aktiengesellschaft	1,700	$0.20M	0.0%	N/A	0.002%
2/14/2023	DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main	52,147	$6.23M	0.0%	+48.1%	0.054%
2/14/2023	Price T Rowe Associates Inc. MD	1,425,290	$170.24M	0.0%	-2.6%	1.483%
2/14/2023	Verition Fund Management LLC	4,766	$0.57M	0.0%	+67.6%	0.005%
2/14/2023	Cetera Advisor Networks LLC	2,151	$0.26M	0.0%	N/A	0.002%
2/14/2023	Cetera Investment Advisers	1,982	$0.24M	0.0%	N/A	0.002%
2/14/2023	Amundi	923,366	$102.02M	0.1%	+13.0%	0.961%
2/14/2023	Laurel Wealth Advisors Inc.	1,719	$0.21M	0.0%	-10.8%	0.002%
2/14/2023	Marshall Wace LLP	30,446	$3.64M	0.0%	N/A	0.032%
2/14/2023	Nelson Van Denburg & Campbell Wealth Management Group LLC	2,282	$0.27M	0.0%	-41.2%	0.002%
2/14/2023	Two Sigma Advisers LP	722,673	$86.32M	0.2%	+21.5%	0.752%
2/14/2023	Campbell & CO Investment Adviser LLC	4,094	$0.49M	0.1%	-31.5%	0.004%
2/14/2023	Two Sigma Investments LP	571,021	$68.20M	0.2%	+54.8%	0.594%
2/14/2023	Arrowstreet Capital Limited Partnership	64,226	$7.67M	0.0%	-69.0%	0.067%
2/14/2023	Engineers Gate Manager LP	4,097	$0.49M	0.0%	N/A	0.004%
2/14/2023	Driehaus Capital Management LLC	241,258	$28.82M	0.4%	+8.4%	0.251%
2/14/2023	Qtron Investments LLC	4,731	$0.57M	0.1%	+146.9%	0.005%
2/14/2023	Townsquare Capital LLC	23,809	$2.84M	0.1%	-10.1%	0.025%
2/13/2023	Advisors Asset Management Inc.	27,358	$3.27M	0.1%	+26.8%	0.028%
2/13/2023	First Republic Investment Management Inc.	11,069	$1.32M	0.0%	+1.0%	0.012%
2/13/2023	Charles Schwab Investment Management Inc.	566,039	$67.61M	0.0%	+4.6%	0.589%
2/13/2023	Brown Advisory Inc.	1,061,661	$126.81M	0.2%	-1.2%	1.104%
2/13/2023	Baird Financial Group Inc.	17,472	$2.09M	0.0%	N/A	0.018%
2/13/2023	BOKF NA	5,057	$0.60M	0.0%	+5.5%	0.005%
2/13/2023	CIBC Asset Management Inc	3,093	$0.37M	0.0%	-27.3%	0.003%
2/13/2023	Bessemer Group Inc.	342	$42K	0.0%	+755.0%	0.000%
2/13/2023	Panagora Asset Management Inc.	10,969	$1.31M	0.0%	-18.8%	0.011%
2/13/2023	Natixis	23,149	$2.76M	0.0%	N/A	0.024%
2/13/2023	Seeyond	20,524	$2.45M	0.2%	-12.8%	0.021%
2/13/2023	Shelton Capital Management	4,897	$0.59M	0.1%	-2.4%	0.005%
2/13/2023	Renaissance Technologies LLC	1,613,664	$192.74M	0.3%	+11.9%	1.679%
2/13/2023	Edgestream Partners L.P.	18,154	$2.17M	0.2%	+106.6%	0.019%
2/13/2023	The Manufacturers Life Insurance Company	101,117	$12.10M	0.0%	-1.3%	0.105%
2/13/2023	Seven Eight Capital LP	1,804	$0.22M	0.1%	N/A	0.002%
2/13/2023	ExodusPoint Capital Management LP	73,006	$8.72M	0.1%	+43.2%	0.076%
2/13/2023	Credit Suisse AG	206,916	$24.71M	0.0%	-0.1%	0.215%
2/13/2023	Martingale Asset Management L P	21,723	$2.60M	0.1%	N/A	0.023%
2/13/2023	Geode Capital Management LLC	1,388,695	$165.69M	0.0%	+5.4%	1.445%
2/13/2023	BI Asset Management Fondsmaeglerselskab A S	4,414	$0.53M	0.0%	N/A	0.005%

Data available starting January 2016

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It discovers, develops, and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Today's Range

Now: $99.21

$98.36

$100.26

50 Day Range

MA: $101.87

$94.11

$111.36

52 Week Range

Now: $99.21

$75.25

$129.29

Volume

789,138 shs

Average Volume

825,513 shs

Market Capitalization

$9.58 billion

P/E Ratio

64.84

Dividend Yield

N/A

Beta

0.5

Who are the company insiders with the largest holdings of Neurocrine Biosciences?: Neurocrine Biosciences' top insider shareholders include:
Neurocrine Biosciences Inc (Major Shareholder)
Kevin Charles Gorman (CEO)
Gary A Lyons (Director)
Eric Benevich (Insider)
William H Rastetter (Director)
Richard F Pops (Director)
Darin Lippoldt (Insider)
Eiry Roberts (Insider)
Stephen A Sherwin (Director)
Matt Abernethy (CFO)
Malcolm Lloyd-Smith (Insider)
Julie Cooke (Insider)
David W Boyer (Insider)
Dimitri E Grigoriadis (Insider)
Kyle Gano (Insider)
Learn More about top insider investors at Neurocrine Biosciences.
Who are the major institutional investors of Neurocrine Biosciences?: Neurocrine Biosciences' top institutional investors include:
JPMorgan Chase & Co. — 2.26%
Avidity Partners Management LP — 1.85%
Renaissance Technologies LLC — 1.68%
Price T Rowe Associates Inc. MD — 1.48%
Geode Capital Management LLC — 1.44%
Brown Advisory Inc. — 1.10%
Learn More about top institutional investors of Neurocrine Biosciences stock.
Which institutional investors are selling Neurocrine Biosciences stock?: During the previous quarter, NBIX stock was sold by these institutional investors:
Armistice Capital LLC
JPMorgan Chase & Co.
Jane Street Group LLC
Congress Asset Management Co. MA
Arrowstreet Capital Limited Partnership
Bank of Nova Scotia
TD Asset Management Inc
First Trust Advisors LP
During the previous year, company insiders that have sold Neurocrine Biosciences company stock include:
Neurocrine Biosciences Inc (Major Shareholder)
Kevin Charles Gorman (CEO)
Gary A Lyons (Director)
Eric Benevich (Insider)
William H Rastetter (Director)
Richard F Pops (Director)
Darin Lippoldt (Insider)
Eiry Roberts (Insider)
Stephen A Sherwin (Director)
Matt Abernethy (CFO)
Malcolm Lloyd-Smith (Insider)
Julie Cooke (Insider)
Learn More investors selling Neurocrine Biosciences stock.
Which institutional investors are buying Neurocrine Biosciences stock?: Within the previous quarter, NBIX stock was bought by institutional investors including:
Norges Bank
Eagle Asset Management Inc.
Millennium Management LLC
1832 Asset Management L.P.
Man Group plc
Fred Alger Management LLC
Two Sigma Investments LP
Renaissance Technologies LLC

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

NBIX Insider Trading

Neurocrine Biosciences Insider Trading History Chart

Neurocrine Biosciences Share Price & Price History

Neurocrine Biosciences Insider Trading History

SEC Filings (Institutional Ownership Changes) for Neurocrine Biosciences (NASDAQ:NBIX)

Institutional Buying and Selling by Quarter

Neurocrine Biosciences Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Neurocrine Biosciences?

Who are the major institutional investors of Neurocrine Biosciences?

Which institutional investors are selling Neurocrine Biosciences stock?

Which institutional investors are buying Neurocrine Biosciences stock?